Cancer remains one of the most strong challenges existing in modern medicine as of today, making it necessary to innovate strategies to combat its relentless progression. Out of the many strategies ...
Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated ...
The list of growth factors involved in tumor angiogenesis has grown substantially and includes vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), endostatin, ...
Nottingham, UK - Angiogenesis and inflammation are central players in the osteoarthritis (OA) disease process, and inhibiting both processes might alter OA progression, according to a review article ...
This past February, for example, Sugen, a division of Peapack, NJ-based Pharmacia, announced it was aborting its Phase III colorectal cancer clinical trial of SU5416, as no clinical benefit was found.
This phase I trial evaluated epigenetic modulation of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor by using a histone deacetylase abexinostat in combination with pazopanib to ...
Copper complexes acting angiogenesis inhibitors have been disclosed in a patent from Istinye Universitesi and Karadeniz Teknik Universitesi Teknoloji Transferi Uygulama ve Arastirma Merkezi as ...
A new study has found that antioxidants like vitamins C and E activate a mechanism that stimulates the growth of new blood vessels in cancer tumors, helping them to grow and spread. The researchers ...
Among the many forms of liver cancer, hepatocellular carcinoma (HCC) is the most common and one of the leading causes of cancer-related deaths worldwide. It is a complex disease with multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback